Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:dronabinol
|
| gptkbp:approvalYear |
1985
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:associatedWith |
gptkb:Cesamet
gptkb:Syndros |
| gptkbp:ATCCode |
A04AD10
|
| gptkbp:chemicalFormula |
synthetic delta-9-tetrahydrocannabinol
|
| gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_III_(US)
|
| gptkbp:drugClass |
Cannabis
|
| gptkbp:form |
soft gelatin capsule
|
| gptkbp:genericName |
gptkb:dronabinol
|
| https://www.w3.org/2000/01/rdf-schema#label |
Marinol
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:AbbVie
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
paranoia drowsiness euphoria dry mouth |
| gptkbp:usedFor |
treatment of nausea and vomiting associated with chemotherapy
treatment of anorexia associated with weight loss in AIDS patients |
| gptkbp:bfsParent |
gptkb:dronabinol
gptkb:Delta-9-THC gptkb:Delta-9-tetrahydrocannabinol |
| gptkbp:bfsLayer |
7
|